CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.84 +0.00 (+0.49%)
At close: Nov 11, 2026 · 4:00 PM EST

CytoMed Therapeutics (GDTC) Change in Acquisitions & Divestments (2023 - 2025)

Updated

CytoMed Therapeutics (GDTC) reported Change in Acquisitions & Divestments of $212,552 for FY2025, down 88.4% from $1.83 million in FY2024.

Analysis

CytoMed Therapeutics (GDTC) Change in Acquisitions & Divestments (2023 - 2025) Analysis & Trends

  • According to Business Quant data, Change in Acquisitions & Divestments came in at $1.83 million in FY2024 and -$2.06 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 CytoMed Therapeutics 9.94 Mn -2.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 214,891.00
Jun 30, 2024 -352,477.00
Dec 31, 2023 -2.10 Mn
Jun 30, 2023 -4.07 Mn
API Access

CytoMed Therapeutics Change in Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-acquisitions-and-divestments&ticker=GDTC&period=max&api_key=YOUR_API_KEY